GlassScriptPhysician profile
David A Seidman
NPI 1932268877
$2,445.91
in general payments reported to CMS, 2019-2025
18 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $106 · 2021: $201 · 2022: $387 · 2023: $553 · 2024: $383 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $521.08 | 2019-2025 | |
| Genzyme Corporation | $437.71 | 2020-2025 | |
| Glaxosmithkline, LLC. | $343.61 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $281.75 | 2021-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $231.00 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $89.23 | 2025 | Tyrvaya |
| Stryker Corporation | $88.77 | 2019-2025 | Clarifix, Xpress Loprofile |
| Bausch & Lomb Americas INC. | $85.43 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Biotissue Holdings INC. | $83.44 | 2023-2024 | |
| Aerin Medical INC. | $50.02 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.28 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $44.30 | 2023 | Ryaltris |
| Thea Pharma INC. | $42.55 | 2023-2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $29.59 | 2020 | |
| Merck Sharp & Dohme LLC | $20.91 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $18.04 | 2019 | |
| Intersect Ent, INC. | $17.41 | 2019 | |
| Alcon Vision LLC | $15.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Seidman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.